Skip to main content

Advertisement

SpringerLink
Log in

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

  • Letter to Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ishikawa Y, Yukawa N, Ohmura K, Hosono Y, Imura Y, Kawabata D, Nojima T, Fujii T, Usui T, Mimori T (2010) Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Rheumatol 29:563–566

    Article  PubMed  Google Scholar 

  2. Martínez-Cordero E, León DE, Ortega LA (2001) Association of polymyositis with rheumatoid arthritis. Rheumatol Int 20:119–123

    Article  PubMed  Google Scholar 

  3. Nagashima T, Onishi S, Kamata Y, Minota S (2009) Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome? Rheumatol Int 29:1261–1262

    Article  PubMed  Google Scholar 

  4. Nagashima T, Iwamoto M, Minota S (2010) Antisynthetase syndrome associated with long-standing rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-00010-01467-00295

    PubMed  Google Scholar 

  5. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019–1038

    CAS  PubMed  Google Scholar 

  6. Schmidt WA, Wetzel W, Friedländer R, Lange R, Sörensen HF, Lichey HJ, Genth E, Mierau R, Gromnica-Ihle E (2000) Clinical and serological aspects of patients with anti-Jo-1 antibodies—an evolving spectrum of disease manifestations. Clin Rheumatol 19:371–377

    Article  CAS  PubMed  Google Scholar 

  7. Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ (2006) Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. J Rheumatol 33:24–30

    CAS  PubMed  Google Scholar 

  8. Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86:242–251

    Article  Google Scholar 

  9. Kiltz U, Fendler C, Braun J (2008) Neuromuscular involvement in rheumatic patients treated with anti-tumor necrosis factor therapy—three examples. J Rheumatol 35:2074–2076

    PubMed  Google Scholar 

  10. Urata Y, Wakai Y, Kowatari K, Nitobe T, Mizushima Y (2006) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Mod Rheumatol 16:410–411

    Article  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, Jichi Medical University, Yakushiji 3311-1, Shimotsuke, Tochigi, 329-0498, Japan

    Takao Nagashima & Seiji Minota

Authors
  1. Takao Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiji Minota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takao Nagashima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagashima, T., Minota, S. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?. Clin Rheumatol 29, 819–820 (2010). https://doi.org/10.1007/s10067-010-1467-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1467-6

Keywords

Search

Navigation